MS comes in several forms, including clinically isolated syndrome, relapsing-remitting MS, secondary progressive MS and primary progressive MS.

The course of MS is difficult to predict. Some people may feel and seem healthy for many years following diagnosis, while others may be severely debilitated very quickly. Most people fit somewhere between these two extremes. Every individual will experience a different combination of MS symptoms, and it is hard to predict how MS will affect a person over their lifetime.

Clinically isolated syndrome

Clinically isolated syndrome (CIS) is the first episode of neurological symptoms experienced by a person, lasting at least 24 hours. The person may experience a single sign or symptom, or more than one at the same time. It is caused by inflammation and demyelination in the central nervous system. CIS is an early sign of MS, but not everyone who experiences CIS goes on to develop MS. Researchers don’t yet know why CIS turns into MS for some people but not others. If someone with CIS also has lesions (as seen on a brain MRI scan) that are similar to those seen in MS, then they are at higher risk. Research suggests that early treatment of CIS can delay conversion to MS for people at high risk.

Relapsing-remitting MS

In relapsing-remitting MS (RRMS, sometimes referred to as relapsing MS), people experience attacks or exacerbations of symptoms (‘relapses’), which then fade or disappear (‘remission’). The symptoms may be new, or existing symptoms may become more severe. Relapses can last for varying periods – from a few days up to months – and then the disease may then be inactive for months or years. About 85 per cent of people with MS are initially diagnosed with RRMS.

RRMS can be categorised by whether it is active or not active (someone who has active MS experiences relapses and/or evidence of new MRI activity). It can also be classified as worsening (a confirmed increase in disability over a specified period of time following a relapse) or not worsening.

Secondary progressive MS

Secondary progressive MS (SPMS) is a secondary phase of relapsing MS that may develop years or even decades following diagnosis with relapsing-remitting MS. Most people who have RRMS will transition to SPMS. In SPMS there is progressive worsening of symptoms over time with no definite periods of remission.

SPMS can be categorised by whether it is active or not active (someone who has active MS experiences relapses and/or evidence of new MRI activity). It can also be classified as with progression (evidence of disease worsening over time, with or without relapses) or without progression.

Primary progressive MS

About 10 to 15 per cent of people with MS are diagnosed with primary progressive MS (PPMS). People with PPMS have steadily worsening symptoms and disability from the start, rather than sudden attacks or relapses followed by recovery.

PPMS can also be categorised by whether it is active or not active (someone who has active MS experiences relapses and/or evidence of new MRI activity). It can also be classified as with progression (evidence of disease worsening over time, with or without relapses) or without progression.

Additional classification of types of MS

For useful descriptions of what active, worsening and progression looks like in relapsing-remitting MS, primary and secondary progressive MS, see the graphs on the National MS Society’s web page here. These characterisations are important as they can affect whether a certain type of treatment will be effective or not.

Here’s what our members say about types of MS

MS Australia

MS Society Canada

National MS Society (USA)

UK MS Society

 

A Greek woman with MS in a motorised scooter

Thessaloniki, Greece, 10/2011. Finding an effective MS therapy has been a particular challenge for Vasiliki Garopoulou; every medication she tried has caused intolerable side effects. On average, she has a relapse once per month, many of which land her in hospital for cortisone treatment. Credit: Maximiliano Braun. Published on this website by kind permission of the European Multiple Sclerosis Platform.

Woman in wheelchair in hospital corridor in China

"It doesn’t matter that I am in a wheelchair. Life goes on. I have just changed the way I get around." Wu Yanxiao, 28, from Beijing, has had MS for 8 years. Reproduced with the kind permission of Li YouHao,© 2014 Li